Statins reduce the incidence of Mesothelioma lung cancer

Washington reported the results of a recent U.S. study that the use of drugs, statins, which work to reduce levels of cholesterol in the blood may reduce the risk of lung cancer by about half.

According to researchers, according to the newspaper “Al” Our study indicates that the drugs have a potential role of statins in the prevention of chemical lung cancer.

And Dr. Vikas Khurana and colleagues at Louisiana State University, there is evidence from animal studies and from laboratory tests on the drugs that have the ability of statins to curb the growth of cancer cells.

The researchers assessed the effects of statins in lung cancer by analyzing data collected by the 6 years from the 483,733 patients included health-care system for veterans.

We report pointed out that the study included 163,662 using statins and drugs for 7280 patients with lung cancer.

Khurana and colleagues found that people who used statins for more than six months fell to their risk of lung cancer by 55% compared with those who did not receive these drugs at all.

Finally, it was noted in the apparent protective effect of age groups and different ethnic group was not dependent on smoking or alcohol or the presence of diabetes.

Ocean

This Mesothelioma News Translated From Arabic Language By Mesothelioma Guide